Gables Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1K Hold
964
﹤0.01% 374
2026
Q1
$5.77K Sell
964
-20
-2% -$150 ﹤0.01% 393
2025
Q4
$7.06K Hold
984
﹤0.01% 377
2025
Q3
$10.5K Sell
984
-27
-3% -$265 ﹤0.01% 355
2025
Q2
$9.79K Hold
1,011
﹤0.01% 359
2025
Q1
$15.1K Hold
1,011
0.01% 324
2024
Q4
$15.1K Hold
1,011
0.01% 328
2024
Q3
$19.3K Hold
1,011
0.01% 301
2024
Q2
$20.9K Sell
1,011
-75
-7% -$1.49K 0.01% 271
2024
Q1
$20.4K Sell
1,086
-10
-0.9% -$172 0.01% 271
2023
Q4
$15.8K Sell
1,096
-20
-2% -$272 0.01% 275
2023
Q3
$19.4K Hold
1,116
0.01% 246
2023
Q2
$23.2K Buy
1,116
+13
+1% +$283 0.02% 243
2023
Q1
$25.9K Hold
1,103
0.02% 234
2022
Q4
$30.8K Sell
1,103
-438
-28% -$11.2K 0.02% 224
2022
Q3
$36K Hold
1,541
0.03% 210
2022
Q2
$52K Hold
1,541
0.04% 197
2022
Q1
$54K Sell
1,541
-30
-2% -$1.03K 0.03% 198
2021
Q4
$48K Sell
1,571
-20
-1% -$651 0.03% 202
2021
Q3
$52K Sell
1,591
-1
-0.1% -$32 0.03% 194
2021
Q2
$48K Buy
+1,592
New +$52.4K 0.03% 202

Other funds holding OGN

Gables Capital Management's OGN Position: Q2 2026 in Review

Gables Capital Management held its Organon & Co (OGN) position steady in Q2 2026 at 964 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #374.

Gables Capital Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $54K in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Gables Capital Management held 964 shares of Organon & Co worth $13.1K as of Q2 2026.
  • Gables Capital Management left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Gables Capital Management's portfolio in Q2 2026, its #374 holding.
  • Gables Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Gables Capital Management's Organon & Co position peaked at $54K in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.